Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000710102 | SCV000612829 | benign | not provided | 2017-07-26 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000517156 | SCV000711905 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Leu581Leu in exon 16 of CLCNKB: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 78.99% (6785/8590) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs2275167). |
Genome- |
RCV001579042 | SCV001806433 | benign | Bartter disease type 4B | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001579043 | SCV001806434 | benign | Bartter disease type 3 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710102 | SCV001889506 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710102 | SCV002418742 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000710102 | SCV005283213 | benign | not provided | criteria provided, single submitter | not provided |